WHO approves emergency use listing for Serum Institute’s Covovax
The World Health Organization (WHO) announced on Friday it has granted Emergency Use Listing (EUL) to Covovax, the coronavirus disease (Covid-19) vaccine developed by the Serum Institute of India (SII) in partnership with the US-based…
Read More...
Read More...